It's too soon to know if the trend will last. But health providers fear the national discourse around vaccines could yield more sickness and death this winter.
You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the ...
A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...
GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...
Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.
Nearly 1,000 flu cases have been reported to the Erie County Department of Health since Oct. 1 but only seven RSV cases have ...
Morning! Today, we preview a contentious generic drug dispute that may end up at the Supreme Court, discuss how the FDA’s new stance on vaccines could impact RSV shots, and more.
MedPage Today on MSN
FDA opens safety review of injectable RSV drugs approved for babies and toddlers
The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback